FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

871701001: Sacituzumab govitecan (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3973908017 Sacituzumab govitecan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3973909013 Sacituzumab govitecan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3973908017 Sacituzumab govitecan en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3973909013 Sacituzumab govitecan (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sacituzumab govitecan Has disposition Topoisomerase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sacituzumab govitecan Is a Topoisomerase inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Sacituzumab govitecan Is modification of (attribute) Sacituzumab false Inferred relationship Existential restriction modifier (core metadata concept)
Sacituzumab govitecan Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Sacituzumab govitecan Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier (core metadata concept)
Sacituzumab govitecan Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing sacituzumab govitecan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sacituzumab govitecan Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only sacituzumab govitecan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sacituzumab govitecan Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing sacituzumab govitecan in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sacituzumab govitecan Inferred relationship Existential restriction modifier (core metadata concept) 1
Sacituzumab govitecan only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sacituzumab govitecan Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start